Muscular dystrophies related to the cytoskeleton/nuclear envelope.

Muscular dystrophies related to the cytoskeleton/nuclear envelope.

Mutations in genes encoding proteins expressed in skeletal muscle cause a significant number of human diseases. Neuromuscular diseases are often severely debilitating for affected individuals, frequently leading to a shortened life span. Identifying the cause of these muscle diseases has provided in...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Nowak, K, McCullagh, K, Poon, E, Davies, K
Format:	Journal article
Język:	English
Wydane:	2005

Podobne zapisy

Utrophin upregulation in Duchenne muscular dystrophy.
od: Hirst, R, i wsp.
Wydane: (2005)

Molecular mechanisms of muscular dystrophies: old and new players.
od: Davies, K, i wsp.
Wydane: (2006)

Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.
od: Nowak, K, i wsp.
Wydane: (2004)

Muscular dystrophy--reason for optimism?
od: Burton, E, i wsp.
Wydane: (2002)

Pharmacological strategies for muscular dystrophy.
od: Khurana, T, i wsp.
Wydane: (2003)

Regenerative biomarkers for Duchenne muscular dystrophy
od: Guiraud, S, i wsp.
Wydane: (2019)

Treating muscular dystrophy with stem cells?
od: Davies, K, i wsp.
Wydane: (2006)

Treating muscular dystrophy with stem cells?
od: Davies, K, i wsp.
Wydane: (2006)

Therapeutic approaches to muscular dystrophy.
od: Goyenvalle, A, i wsp.
Wydane: (2011)

Duchenne muscular dystrophy - past, present and future
od: Davies, K
Wydane: (2002)

Progress in therapy for Duchenne muscular dystrophy.
od: Fairclough, R, i wsp.
Wydane: (2011)

Progress in therapy for Duchenne muscular dystrophy
od: Fairclough, R, i wsp.
Wydane: (2011)

Pharmacological advances for treatment in Duchenne muscular dystrophy
od: Guiraud, S, i wsp.
Wydane: (2017)

The allure of stem cell therapy for muscular dystrophy.
od: Grounds, MD, i wsp.
Wydane: (2007)

The Pathogenesis and Therapy of Muscular Dystrophies
od: Guiraud, S, i wsp.
Wydane: (2015)

Expression of different isoforms of utrophin in human muscle; potentials for therapy of Duchenne muscular dystrophy
od: Sewry, C, i wsp.
Wydane: (2004)

The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
od: Perkins, K, i wsp.
Wydane: (2002)

Utrophin in the therapy of Duchenne Muscular Dystrophy
od: Potter, A, i wsp.
Wydane: (2006)

Muscular dystrophy: from gene to patient.
od: Hopkins, J, i wsp.
Wydane: (2000)

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy.
od: Goyenvalle, A, i wsp.
Wydane: (2011)

Regenerative biomarkers for Duchenne muscular dystrophy
od: Simon Guiraud, i wsp.
Wydane: (2019-01-01)

Immunocytochemistry of nuclear domains and Emery-Dreifuss muscular dystrophy pathophysiology
od: NM Maraldi, i wsp.
Wydane: (2009-06-01)

Advances in genetic therapeutic strategies for Duchenne muscular dystrophy
od: Guiraud, S, i wsp.
Wydane: (2015)

Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1
od: Stefan Hintze, i wsp.
Wydane: (2018-10-01)

Protein interactions at the higher plant nuclear envelope: evidence for a Linker of Nucleoskeleton and Cytoskeleton complex.
od: David Edgar Evans, i wsp.
Wydane: (2014-05-01)

Surrogate gene therapy for muscular dystrophy
od: Davies, KE, i wsp.
Wydane: (2019)

Pharmacologically targeting the primary defect and downstream pathology in Duchenne muscular dystrophy.
od: Fairclough, R, i wsp.
Wydane: (2012)

Muscular Dystrophy /
od: Naff, Clay Farris, editor 192865, i wsp.
Wydane: (2012)

Therapeutic approaches for Duchenne muscular dystrophy
od: Roberts, TC, i wsp.
Wydane: (2023)

Modified patient stem cells as prelude to autologous treatment of muscular dystrophy.
od: Davies, K, i wsp.
Wydane: (2007)

Mitochondrial abnormalities in oculopharyngeal muscular dystrophy
od: Wong, K.T., i wsp.
Wydane: (1996)

Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy.
od: Metzinger, L, i wsp.
Wydane: (1997)

Micro-dystrophin genes bring hope of an effective therapy for duchenne muscular dystrophy
od: Davies, K, i wsp.
Wydane: (2019)

Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy
od: Rocío Bengoechea, i wsp.
Wydane: (2012-04-01)

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
od: Griffin, J, i wsp.
Wydane: (2002)

Nesprin proteins: bridging nuclear envelope dynamics to muscular dysfunction
od: Zhou Zi-yi, i wsp.
Wydane: (2024-04-01)

Delay in Diagnosis of Duchenne Muscular Dystrophy
od: Vamshi K Rao, i wsp.
Wydane: (2015-01-01)

Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches.
od: Fairclough, R, i wsp.
Wydane: (2013)

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
od: Goyenvalle Aurélie, i wsp.
Wydane: (2011-02-01)

Increased muscle lim protein expression associated with mild muscular dystrophy and with exercise
od: Wilding, JR, i wsp.
Wydane: (2001)